Dr. Spyridon A. Mastroyannis, MD
- Medicare services, 2024
- 229
- Medicare patients, 2024
- 115
- Part D claims, 2024
- 170
- Publications
- 25
- Hospital affiliations
- 6
- Practice address
- 2695 Rocky Mountain Ave, Loveland, CO 80538
- Practice phone
- Call (970) 203-7050
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
UCHealth Medical Group
Loveland, Colorado
Find Dr. Mastroyannis' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Spyridon A. Mastroyannis is a gynecologic oncologist in Loveland, Colorado
Dr. Mastroyannis practices at UCHealth Medical Group in Loveland, Colorado.
Dr. Mastroyannis' NPI, 1700272986, was assigned on April 14, 2015. Dr. Mastroyannis graduated from George Washington University School of Medicine in 2015. Dr. Mastroyannis holds Colorado license DR.0068092.
- NPI
- 1700272986NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4880990142
- NPI enumeration date
- April 14, 2015
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (970) 203-7050
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 37
- Medical school graduation
- 2015
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Spyridon A. Mastroyannis practices at UCHealth Medical Group in Loveland, Colorado
Dr. Mastroyannis' primary practice is UCHealth Medical Group, at 2695 Rocky Mountain Ave, Loveland, CO 80538 in Larimer County. The practice phone is (970) 203-7050.
- UCHealth Medical Group2695 Rocky Mountain Ave, Loveland, CO 80538 · Larimer CountyPhone(970) 203-7050
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Spyridon A. Mastroyannis is affiliated with 8 sites of care and 2 medical groups
Dr. Mastroyannis' primary practice is UCHealth Medical Group in Loveland, Colorado. Dr. Mastroyannis is also affiliated with UCHealth Medical Center of the Rockies. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Mastroyannis to 5 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Spyridon A. Mastroyannis' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mastroyannis practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UCHealth Medical Group | Available with a free account |
| +7 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Spyridon A. Mastroyannis is one of 32 gynecologic oncologists in Colorado
Gynecologic oncology is Dr. Mastroyannis' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Mastroyannis is licensed in Colorado.
Specialties and state licenses
- Gynecologic oncology, ColoradoPrimary
Gynecologic oncologists near Dr. Mastroyannis
Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Spyridon A. Mastroyannis billed Medicare for 229 services in 2024
CMS data shows 229 Medicare services from Dr. Mastroyannis across 8 procedure codes in 2024, for 115 Medicare patients. Medicare paid $31,695 for them.
Dr. Mastroyannis' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1042024: 15650%
- Other services
- 2023: 02024: 37
- Surgery
- 2023: 122024: 36200%
Where Dr. Mastroyannis' Medicare services took place, 2024
- In an office4419%
- In a facility18581%
Dr. Mastroyannis compared with the Colorado median for gynecologic oncologists, 2024
- Dr. Mastroyannis
- Colorado median
- Medicare services
- 229vs 16440% above
- Medicare patients
- 115vs 9126% above
- Part D claims
- 46vs 4015% above
Medians across 30 gynecologic oncologists in Colorado with Dmand AI profiles that report each measure.
Dr. Mastroyannis' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mastroyannis?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mastroyannis and other gynecologic oncologists in Colorado.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Spyridon A. Mastroyannis treated 115 Medicare patients in 2024, average age 73
CMS counts 115 Medicare patients who saw Dr. Mastroyannis in 2024. The largest group is 65 to 74, with 70 patients. 66% of them have high blood pressure, and 63% have cancer. 16% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mastroyannis' median patient age at 70, with 99% women.
Dr. Mastroyannis' Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Mastroyannis' Medicare patients, 2024
- High blood pressure66%
- Cancer63%
- High cholesterol61%
- Arthritis38%
- Anxiety26%
- Ischemic heart disease25%
- Mood disorders25%
- Depression23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mastroyannis' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women99%
- Men1%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Spyridon A. Mastroyannis wrote 170 Medicare Part D claims in 2024
In 2024, Dr. Mastroyannis wrote 170 Medicare Part D claims for 57 patients. 71% of them were for generic drugs. CMS names the drug for 46 of them, across 2 drugs with 11 or more claims each, at $20,438 in total drug cost. In 2023, CMS named 58 claims across 4 drugs.
Dr. Mastroyannis' Part D claims by kind of drug, 2024
- Generic120 claims71%
- Brand-name50 claims29%
Dr. Mastroyannis' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Mastroyannis' Part D claims, 2024
- Opioids8%13 of 170 claims
- Antibiotics12%20 of 170 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 582024: 4621%
Drugs named by CMS: 2 in 2024, 4 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Spyridon A. Mastroyannis ranks in the 95th percentile for removal of the uterus in Medicare
Dr. Mastroyannis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mastroyannis as offering telehealth. CMS counts 26 procedures of removal of the uterus by Dr. Mastroyannis, more than 95% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Where Dr. Mastroyannis ranks in Medicare procedure volume
- Removal of the uterus
- 95th percentile26 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Spyridon A. Mastroyannis has 25 publications on record
Dmand AI links 25 papers to Dr. Mastroyannis, published from 2013 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial and Hysterectomy. Dr. Mastroyannis has published most often in Gynecol Oncol. Dr. Mastroyannis' most frequent co-authors are Dimitrios Nasioudis, MD, Emily M. Ko, MD and Lori Amanda Cory, MD.
Dr. Mastroyannis' papers by year, 2015 to 2025
Topics Dr. Mastroyannis writes about most
- Ovarian Neoplasms
- Carcinoma, Ovarian Epithelial
- Hysterectomy
- Lymph Node Excision
- Sentinel Lymph Node Biopsy
- Uterine Neoplasms
- Chemotherapy, Adjuvant
- Endometrial Neoplasms
Dr. Mastroyannis' most frequent co-authors
- Dimitrios Nasioudis, MD12 shared papers
- Emily M. Ko, MD11 shared papers
- Lori Amanda Cory, MD3 shared papers
Recent publications by Dr. Mastroyannis
Int J Gynecol Cancer
See who Dr. Mastroyannis researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mastroyannis works with, so you can find a warm path to the right gynecologic oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Spyridon A. Mastroyannis received $100 in industry payments from 2023 to 2025
CMS Open Payments shows 3 general payments to Dr. Mastroyannis from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Caris MPI, Inc. paid the most, $43.
General payments to Dr. Mastroyannis by program year, 2023 to 2025
Companies that paid Dr. Mastroyannis the most, 2023 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Spyridon A. Mastroyannis graduated from George Washington University School of Medicine
Dr. Mastroyannis graduated from George Washington University School of Medicine in 2015.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Spyridon A. Mastroyannis's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Spyridon A. Mastroyannis
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Spyridon A. Mastroyannis' NPI number?
Dr. Spyridon A. Mastroyannis' NPI number is 1700272986. It was assigned on April 14, 2015, and it is active in the NPI Registry.
What kind of doctor is Dr. Spyridon A. Mastroyannis?
Dr. Spyridon A. Mastroyannis is a gynecologic oncologist in Loveland, Colorado. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).
Where does Dr. Spyridon A. Mastroyannis practice?
Dr. Mastroyannis practices at 2695 Rocky Mountain Ave, Loveland, CO 80538. Dr. Mastroyannis' primary practice is UCHealth Medical Group in Loveland, Colorado. Dmand AI also links Dr. Mastroyannis to 5 hospitals, 1 group practice or clinic and 1 medical group.
What is Dr. Spyridon A. Mastroyannis' office phone number?
The practice phone on file for Dr. Mastroyannis is (970) 203-7050.
What is Dr. Spyridon A. Mastroyannis' medical license number?
Dr. Mastroyannis holds Colorado license DR.0068092.
Which hospitals is Dr. Spyridon A. Mastroyannis affiliated with?
Dr. Mastroyannis is affiliated with UCHealth Medical Center of the Rockies. Dmand AI links Dr. Mastroyannis to 5 more hospitals.
What medical group is Dr. Spyridon A. Mastroyannis part of?
Dr. Mastroyannis is linked to University of Colorado Medicine (CU Medicine). Dmand AI links Dr. Mastroyannis to 1 more medical group.
Does Dr. Spyridon A. Mastroyannis accept Medicare?
Yes. CMS data shows Dr. Mastroyannis billed Medicare for 229 services in 2024, and Dr. Mastroyannis accepts Medicare assignment.
Does Dr. Spyridon A. Mastroyannis offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mastroyannis as offering telehealth services.
How many Medicare patients does Dr. Spyridon A. Mastroyannis see?
CMS counts 115 Medicare patients who saw Dr. Mastroyannis in 2024, with an average age of 73.
Show 7 more questionsShow fewer questions
What services does Dr. Spyridon A. Mastroyannis bill to Medicare?
In 2024, Dr. Mastroyannis' most billed Medicare services were office visit, new patient (99205), office visit, established patient (99215) and medicare service (G2211).
Where did Dr. Spyridon A. Mastroyannis go to medical school?
Dr. Mastroyannis graduated from George Washington University School of Medicine in 2015.
What drugs does Dr. Spyridon A. Mastroyannis prescribe most?
In 2024 Medicare Part D data, Dr. Mastroyannis' most prescribed drugs by claims were Eliquis and Imiquimod.
Has Dr. Spyridon A. Mastroyannis received payments from drug or device companies?
CMS Open Payments shows $100 in general payments to Dr. Mastroyannis from 3 companies from 2023 to 2025. The largest total came from Caris MPI, Inc.
How long has Dr. Spyridon A. Mastroyannis been practicing?
Dr. Mastroyannis graduated from medical school in 2015, 11 years ago.
Does Dr. Spyridon A. Mastroyannis do research?
Dmand AI links 25 publications to Dr. Mastroyannis, published from 2013 to 2025.
Who does Dr. Spyridon A. Mastroyannis publish with?
Dr. Mastroyannis' most frequent co-authors are Dimitrios Nasioudis, MD (12 shared papers), Emily M. Ko, MD (11 shared papers) and Lori Amanda Cory, MD (3 shared papers).
Selling to gynecologic oncology practices?
See gynecologic oncologists in Colorado by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card